India to Netherlands: Rivaroxaban Export Trade Route

The India to Netherlands Rivaroxaban corridor is one of India's established pharmaceutical export routes, with 229 shipments documented worth a combined $15.7M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 99% of all export value, reflecting the consolidated nature of India's rivaroxaban manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $68.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with rivaroxaban's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 10.1%, placing it at rank #15 among India's top rivaroxaban export destinations globally.

On the import side, key buyers of Indian rivaroxaban in Netherlands include MYLAN IRELAND C/O ALLOGA RDC,, MYLAN IRELAND C/O ALLOGA RDC,., MYLAN IRELAND and 16 others. MYLAN IRELAND C/O ALLOGA RDC, is the single largest importer with 64 shipments valued at $13.0M USD.

India's rivaroxaban exports to Netherlands are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 195 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Netherlands benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, INTAS PHARMACEUTICALS LIMITED, DR REDDY S LABORATORIES LTD — together account for 100% of total trade value on this route. The average shipment value of $68.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicines, rivaroxaban tab 10mg100bl dk/is/no via (5081 packs) and harmless medicines, rivaroxaban tab 10mg30bl uk my (46577 packs), suggesting that buyers in Netherlands tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MYLAN IRELAND C/O ALLOGA RDC, is the largest importer with 64 shipments worth $13.0M USD — representing 83% of all rivaroxaban imports from India on this route. A total of 19 buyers are active on this corridor.